Internal Reference Number: FOI_6962
Date Request Received: 13/01/2023 00:00:00
Date Request Replied To: 27/01/2023 00:00:00
This response was sent via: By Email
Request Summary: Epilepsy Treatment
Request Category: Private Individuals
Question Number 1: I would like to please request the following information, with regards to treatment of Epilepsy in your trust/ board. In the last 12 months of available data: a) What number of unique patients have been treated for Lennox-Gastaut syndrome, Dravet Syndrome and Tuberous Sclerosis Complex? Please give answers for each condition separately. b) For each indication (Lennox-Gastaut syndrome, Dravet Syndrome and Tuberous Sclerosis Complex), what number of these have been treated in a paediatric environment? | |
Answer To Question 1: a& b, Paediatrics - Dravet <5 patients, TS complex 3<5 patients, Lennox -gastaut 0 patients | |
Question Number 2: How many patients have been treated with Epidyolex in a paediatric environment? | |
Answer To Question 2: <5 patients have been treated with epidyolex (cannabidiol) in a paediatric environment. These patients are prescribed the cannabidiol by the Southampton paediatric neurology team - this is nationally recorded through the blueteq system | |
Question Number 3: Can you please detail which ¿´Æ¬Èí¼þ Trusts/ Health Boards these patients have been referred from? | |
Answer To Question 3: <5 patients are under the care of Southampton paediatric neurology | |
To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of ¿´Æ¬Èí¼þ Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.